Navigation Links
Aspreva obtains shareholder approval for acquisition by Galenica
Date:12/17/2007

VICTORIA, BC, Dec. 17 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) today announced that Aspreva's shareholders and optionholders have approved the proposed acquisition of Aspreva by Galenica Group (SWX: GALN), through a wholly-owned Canadian subsidiary, at a price of US$26.00 per share in cash. At the special meeting of securityholders held this morning, the transaction was approved by over 99% of the votes cast by shareholders and by over 99% of the votes cast by shareholders and optionholders, voting together as a class.

The transaction is being carried out by way of a statutory plan of arrangement under Section 288 of the British Columbia Business Corporations Act. The closing of the transaction remains subject to final court approval, approval by the Minister of Industry under the Investment Canada Act, as well as the satisfaction or waiver of the conditions specified in the Combination Agreement entered into on October 17, 2007. An application for final court approval is scheduled to be heard by the British Columbia Supreme Court on December 18, 2007. Subject to court approval being obtained, receipt of approval by the Minister of Industry under the Investment Canada Act and the other conditions to closing being satisfied or waived, the transaction is expected to close on January 3, 2008.

Shareholders also today approved an amendment to Aspreva's shareholder rights plan in order to facilitate the proposed acquisition of Aspreva by Galenica Group.

Further details regarding the terms of the transaction are set out in Aspreva's management information circular dated November 15, 2007, which was filed by Aspreva on the Canadian SEDAR website at '/>"/>

SOURCE Aspreva Pharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Aspreva to Announce 2007 Third Quarter Results on October 31st
2. Aspreva Announces Preliminary Revenues for Third Quarter 2007
3. Aspreva to be Acquired by Galenica For US$915 Million
4. Aspreva Sends Materials for Special Meeting to be Held December 17
5. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
6. Patient Lift Manufacturer, Medcare Products, Obtains Women-Owned Certification
7. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
8. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
9. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
10. United Medicorp, Inc.s Shareholders Approve All Proposals
11. Arrow International Sends Letter Reminding Shareholders to Vote White Proxy Card in Support of Teleflex Merger and Election of Current Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased ... brand’s new logo and optimized website. , ... approach to expert diagnostic imaging, centered on patient care. ... to be a resource for Nebraska patients and a ... communication and referral functionality, video content and resources to ...
(Date:3/5/2015)... 05, 2015 HomeCEUConnection.com is ... with extra savings on their nutrition CEUs. ... health and nutrition, HomeCEUConnection.com is offering 10% ... promo code, NUTRITION2015 . , High ... , HomeCEUConnection.com provides high-quality continuing education courses ...
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 On ... titled “Butt Augmentation, Labiaplasty on the Rise, Plastic Surgeons ... by the American Society for Aesthetic Plastic Surgery ... . Both groups reported a year-over-year doubling of surgical ... the physicians quoted in the article, this increase can ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 In honor ... to shatter myths about drug and alcohol abuse in ... released a Fact Sheet with information on some of ... in 2010 by the National Institute on Drug Abuse, ... alcohol aims to counteract the illusions that teens and ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction ... treatment met today in Jackson, Mississippi to listen to ... the numerous respected speakers will be William S. ... that pain medications have had in today’s opiate overdose ... "It is hard to believe that much of the ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3
... Rights to Bystolic(TM) (Nebivolol) for $370 Million in Cash ... To Consider a Sale of Dey Specialty Business, PITTSBURGH, Feb. ... results for the three and nine months ended,December 31, 2007, provided ... announced a number of strategic and operational,initiatives., Financial Highlights, ...
... New research from a scientist at the University of ... to a better flu vaccine. , While the research ... findings from Mark Sangster, a professor of microbiology, track ... infection and reveal new information about where it is ...
... University School of Medicine and Harvard Medical School have ... of high blood pressure, reduces cocaine cravings in a ... issue of the leading medical journal Nature Neuroscience. , ... glutamate, independently contribute to the development of cocaine addiction. ...
... ROCKVILLE, Md., Feb. 27 Novavax, Inc.,(Nasdaq: NVAX ... Singhvi, President and Chief Executive Officer, will be presenting ... 12:30 p.m. on March 4, 2008 at The W ... of the company,s strategy, research and,development progress. A link ...
... 27 Dr. Shawn Hook of Arbor Ridge,Clinic in ... Summit,VetPharm,s "The Great Vectra 3D(TM)" $125,000 Giveaway. Dr. Hook ... receive $25,000 in,medical equipment for his veterinary clinic. There ... February and March, and a final grand prize,winner who ...
... numbers of circulating,cancer cells in a blood sample; ... RARITAN, N.J., Feb. 27 Veridex, LLC ... (FDA) has granted an expanded,clearance for the CellSearch(TM) ... the,monitoring of metastatic prostate cancer (MPC) patients. The ...
Cached Medicine News:Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 2Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 4Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 5Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 6Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 7Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 8Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 9Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 10Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 11Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 12Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 13Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 14Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 15Health News:UT Knoxville research may lead to better flu vaccine 2Health News:Summit VetPharm Announces First Winner in its 'Great Vectra 3D(TM)' $125,000 Giveaway 2Health News:FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients 2Health News:FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients 3Health News:FDA Clears Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients 4
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5. März 2015  Die amerikanische Bill ... biopharmazeutische Unternehmen CureVac geben heute bekannt, dass ... US-Dollar) in CureVac investiert. CureVac ist weltweit ... (mRNA). Auf Basis dieses Moleküls entwickelt CureVac ... und zum Schutz vor Infektionskrankheiten. ...
(Date:3/5/2015)... -- CANTEL MEDICAL CORP. (NYSE: CMN ) will ... 2015 on Thursday, March 12 before the market opens, and ... AM ET. To participate in the conference ... the beginning of the call. If you are unable to ... from Thursday, March 12, 2015 through midnight on May 12, ...
Breaking Medicine Technology:BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2
...  BioMed Realty Trust, Inc. (NYSE: BMR ) ... with Depomed, Inc. (NASDAQ: DEPO ) at ... a specialty pharmaceutical company, leased approximately 60,000 square feet ... Realty,s multi-tenant Pacific Research Center campus. Commenting ...
... Fla., April 9, 2012 Med-Tek a developer of Healthcare ... physicians, employers and their constituents today announces the launch ... According to the United States Bone ... individuals suffering from musculoskeletal disease ...
Cached Medicine Technology:New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 2New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed 3Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2
Colloidal Gold Conjugated, Goat anti-human IgA (Alpha Chain) - 50 OD...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Sol, 80 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: